Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance against reverse transcriptase inhibitors.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jun 2000

O'Brien W A

Abstract excerpt

The response to antiretroviral therapy in human immunodeficiency virus (HIV)-infected patients is limited by the emergence of drug resistance. This resistance is a consequence of the high rate of HIV mutation, the high rate of viral replication (especially when potent multidrug therapies are not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Infections
Share to Mutation
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Resistance, Multiple

Share to Drug Therapy, Combination

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 10860904
DOI: 10.1086/313858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-10860904-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance against reverse transcriptase inhibitors.PMID 10860904Read ↗

Resistance to antiretroviral drugs.Semantic proximity Read ↗

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase InhibitorsSemantic proximity Read ↗

Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection.Semantic proximity Read ↗

HIV resistance to reverse transcriptase inhibitors.Semantic proximity Read ↗

Protease inhibitor resistance update: where are we now?Semantic proximity Read ↗

Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance.Semantic proximity Read ↗

Resistance to protease inhibitors.Semantic proximity Read ↗

Mechanisms of anti-retroviral drug resistance: implications for novel drug discovery and development.Semantic proximity Read ↗

Human immunodeficiency viruses and drug therapy: resistance and implications for antiretroviral therapy.Semantic proximity Read ↗

HIV resistance: the new enemy.Semantic proximity Read ↗

Avoiding Drug Resistance in HIV Reverse Transcriptase.Semantic proximity Read ↗

Current insights into reverse transcriptase inhibitor-associated resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.